Cocrystal Pharma up after appointing James Sapirstein as CEO

Cocrystal Pharma

03/06/2026 12:42

** Shares of drug developer Cocrystal Pharma COCP.O rise 5.1% to $1.10 premarket 
** Co appoints James Sapirstein as chief executive officer, effective immediately
** It also plans to appoint Sapirstein to the company's board as director
** Sapirstein replaces Sam Lee and Jim Martin, who served as co-CEOs
** Sam Lee will continue as president and transition to chief scientific officer, and Jim Martin will continue as CFO 
** Up to last close, stock is down 37.5% YTD 

 (Reporting by Siddhi Mahatole)
 ((siddhi.mahatole@thomsonreuters.com))